Beit Jala Pharmaceutical Company announced audited earnings results for the year ended December 31, 2018. For the year, the company reported sales of JOD 7,036,939 against JOD 8,323,963 a year ago. Net income after tax was JOD 772,790 against JOD 1,645,697 a year ago. Basic and diluted earnings per share were JOD 0.110 against JOD 0.235 a year ago.